TY - JOUR
T1 - SARS-CoV-2 associated pathogenesis, immune dysfunction and involvement of host factors
T2 - A comprehensive review
AU - Waqar, W.
AU - Ismail, S.
AU - Jamil, Z.
AU - Al-Shehhi, A.
AU - Imran, M.
AU - Hetta, H. F.
AU - Muhammad, Khalid
AU - Waheed, Yasir
N1 - Publisher Copyright:
© 2021 Verduci Editore s.r.l. All rights reserved.
PY - 2021
Y1 - 2021
N2 - Infectious diseases, especially viral infections, have emerged as a major concern for public health in recent years. Recently emerged COVID-19, caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), has been declared a pandemic by World Health Organization since March 2020. It was first identified in Wuhan, China, in December 2019 and has since claimed more than a million lives. Complicated symptoms are associated with rising incidence and fatality rates, while many of the vaccine candidates are in the final stages of clinical trials. This review encompasses a summary of existing literature on COVID-19, including the basics of the disease such as the causative agent's genome characterization, modes of transmission of the virus, pathogenesis, and clinical presentations like associated immune responses, neurological manifestations, the variety of host genetic factors influencing the disease and the vulnerability of different groups being affected by COVID-19.
AB - Infectious diseases, especially viral infections, have emerged as a major concern for public health in recent years. Recently emerged COVID-19, caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), has been declared a pandemic by World Health Organization since March 2020. It was first identified in Wuhan, China, in December 2019 and has since claimed more than a million lives. Complicated symptoms are associated with rising incidence and fatality rates, while many of the vaccine candidates are in the final stages of clinical trials. This review encompasses a summary of existing literature on COVID-19, including the basics of the disease such as the causative agent's genome characterization, modes of transmission of the virus, pathogenesis, and clinical presentations like associated immune responses, neurological manifestations, the variety of host genetic factors influencing the disease and the vulnerability of different groups being affected by COVID-19.
KW - COVID-19
KW - Host factors
KW - Immune response
KW - Pathogenesis
KW - SARS-CoV-2 infection
UR - http://www.scopus.com/inward/record.url?scp=85121987632&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85121987632&partnerID=8YFLogxK
U2 - 10.26355/eurrev_202112_27453
DO - 10.26355/eurrev_202112_27453
M3 - Review article
C2 - 34919255
AN - SCOPUS:85121987632
SN - 1128-3602
VL - 25
SP - 7526
EP - 7542
JO - European review for medical and pharmacological sciences
JF - European review for medical and pharmacological sciences
IS - 23
ER -